A new study published today in JAMA Network Open found that removing olfactory groove meningioma - a type of brain tumor ...

Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its ...

MD Anderson-led Phase II trial suggests neoadjuvant immunotherapy is safe and may be an effective option for patients with soft-tissue sarcomas After treatment with a combination of immunotherapy and ...

A new end-to-end PET imaging approach for osteosarcoma can rapidly and reliably distinguish tumor tissue from normal tissue ...

GT Medical Technologies announced today that it closed an oversubscribed $100 million Series E equity financing.

Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the time of surgery and promising long-term survival, according to Phase II ...

A new study published today in JAMA Network Open found that removing olfactory groove meningioma — a type of brain tumor located near the base of the brain — may improve blood sugar control in ...